Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach

American Journal of Pathology

Volumn 149, Issue 5, 1996, Pages 1449-1457

  Krajewska, Maryla ^a   Fenoglio Preiser, Cecilia M ^b   Krajewski, Stanislaw ^a   Song, Ki ^a   Macdonald, John S ^c   Stemmerman, Grant ^b   Reed, John C ^a,d  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY HEALTH SYSTEM   (United States)

^d The Leukemia & Lymphoma Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; ETIOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; TUMOR CELL;

ADENOCARCINOMA; HUMANS; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS;

EID: 0029855440     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Williams GT: Programmed cell death: apoptosis and oncogenesis. Cell 1991, 65:1097-1098
2. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992, 80: 879-886
3. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6
4. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456-1462
5. Tsujimoto Y, Cossman J, Jaffe E, Croce C: Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985, 228:1440-1443
6. Vaux DL, Cory S, Adams JM: bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988, 335:440-442
7. Hockenbery DM, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990, 348:334-336
8. Reed JC: Bcl-2: prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 1995, 9:451-474
9. Ruoslahti E, Reed JC: Anchorage dependence, integrins, and apoptosis. Cell 1994, 77:477-478
10. Oltvai Z, Milliman C, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619
11. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993, 74:597-608
12. Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A, Craig RW: Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 1994, 54:6348-6352
13. Farrow SN, White JHM, Martinou I, Raven T, Pun K-T, Grinham CJ, Martinou J-C, Brown R: Cloning of a Bcl-2 homologue by interaction with adenovirus E1B 19K. Nature 1995, 374:731-733
14. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, Guild BC: Induction of apoptosis by the Bcl-2 homologue Bak. Nature 1995, 374:733-736
15. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Ubansky SR, Tomei LD, Barr PJ: Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995, 374:736-739
16. Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. CA-Cancer J Clin 1995, 45:8-30
17. Robbins, I: The gastrointestinal tract. Pathologic Basis of Disease. Edited by JM Crawford. Philadelphia, WB Saunders Co, 1994, pp 755-831
18. Dixon, MF: Progress in gastric cancer. Progress in Pathology. Edited by N Kirkham, P Hall. New York, Churchill Livingstone, 1995, pp 13-30
19. Stevens A, Lowe J: Disease of the stomach. Pathology. St. Louis, Mosby, 1995, pp 221-225
20. Krajewski S, Krajewska M, Shabaik A, Wang H-G, Irie S, Fong L, Reed JC: Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res 1994, 54:5501-5507
21. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC: Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 1994, 145:515-525
22. Krajewski S, Chatten J, Hanada M, Womer R, Reed JC: Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Lab Invest 1994, 72:42
23. Krajewski S, Blomvqvist C, Franssila K, Krajewska M, Wasenius V-M, Niskanen E, Reed JC: Reduced expression of pro-apoptotic gene bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 1995, 55:4471-4478
24. Krajewski S, Krajewska M, Reed JC: Immunohistochemical analysis of in vivo patterns of Bak expression, a pro-apoptotic member of the Bcl-2 protein family. Cancer Res 1996, 56:2849-2855
25. Krajewska M, Moss S, Krajewski S, Song K, Holt P. Reed JC: Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996, 56:2422-2427
26. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC: Investigations of the subcellular distribution of the Bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 1993, 53: 4701-4714
27. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang H-G, Reed JC: Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 1994, 145:1323-1333
28. Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K, Reed JC: Immunohistochemical analysis of Mcl-1 protein in human tissues: differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 1995, 146:1309-1319
29. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY: Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990, 137:225
30. Furuya Y, Krajewski S, Epstein JI, Reed JC, Isaacs JT: Enhanced expression of Bcl-2 and the progression of human and rodent prostatic cancers. Clin Cancer Res 1996, 2:389-398
31. Tahara E: Molecular biology of gastric cancer. World J Surg 1995, 19:484-490
32. Ayhan A, Yasui W, Yokozaki H, Seto M, Ueda R, Tahara E: Loss of heterozygosity at the bcl-2 gene locus and expression of bcl-2 in human gastric and colorectal carcinomas. Jpn J Cancer Res 1994, 85:584-591
33. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein L, Fischer A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996, 271:350-352
34. Broome HE, Dargan CM, Krajewski S, Reed JC: The expression of Bcl-2, Bcl-X, and Bax after T-cell activation and IL-2 withdrawal. J Immunol 1995, 155:2311-2317
35. Krajewski S, Mai JK, Krajewska M, Sikorska M, Mossakowski MJ, Reed JC: Upregulation of Bax protein levels in neurons following cerebral ischemia. J Neurosci 1995, 15:6364-6376
36. Krajewski S, Epstein JI, Shabaik A, Krajewska M, Sauvageot J, Reed JC: Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in prostate cancers. Am J Pathol 1996, 148:1567-1576
37. Knudson CM, Tung KSK, Tourtellotte WG, Brown GAJ, Korsmeyer SJ: Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995, 270:96-99
38. Bargou RC, Daniel PT, Mapara MY, Bommert K, Wagenert K, Wagener C, Kallinich B, Royer HD, Dörken B: Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-a expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 1995, 60:854-859